Prostate biopsy · Massachusetts
Prostate biopsy in Massachusetts: the highest-volume physicians
121 physicians in Massachusetts billed Medicare for 3,586 prostate biopsy procedures in 2024. The top 25, with the year before beside it.
Top 25
| Rank | Physician | 2024 | 2023 | Change |
|---|---|---|---|---|
| 1 | Mitchell H. Sokoloff, MDUrology · Worcester | 123 | 103 | +19% |
| 2 | Arthur F. Little, MDUrology · Stoneham | 116 | 75 | +55% |
| 3 | William C. Faust, MDUrology · Burlington | 84 | 95 | −12% |
| 4 | Michael C. Lee, MDUrology · Boston | 78 | 42 | +86% |
| 5 | Aria F. Olumi, MD FACSUrology · Boston | 71 | 57 | +25% |
| 6 | Michael J. Curran, MDUrology · Norwood | 69 | 49 | +41% |
| 6 | Justin M. Zbrzezny, MDUrology · Needham | 69 | 61 | +13% |
| 8 | Alexander P. Cole, MDUrology · Boston | 65 | 59 | +10% |
| 9 | John P. Long, MDUrology · Newton | 62 | 50 | +24% |
| 10 | Michael A. Geffin, MDUrology · Plymouth | 61 | 37 | +65% |
| 11 | Tony Luongo, MDUrology · Boston | 59 | 24 | +146% |
| 11 | J M. Massicotte, MDUrology · Chelmsford | 59 | 57 | +4% |
| 13 | Adam S. Feldman, MDUrology · Boston | 58 | 47 | +23% |
| 13 | Douglas M. Dahl, MDUrology · Boston | 58 | 41 | +41% |
| 15 | Evangelos G. Geraniotis, MDUrology · Hyannis | 56 | 41 | +37% |
| 15 | Jonathan S. BrajtbordUrology · North Easton | 56 | 35 | +60% |
| 17 | Andrew I. Kim, MDUrology · Springfield | 54 | 27 | +100% |
| 18 | Yigal S. Litvin, MDUrology · Pittsfield | 50 | 46 | +9% |
| 19 | Mark Laspina, DOUrology · Salem | 47 | 63 | −25% |
| 20 | Micah L. Hemani, MDUrology · Dedham | 46 | 25 | +84% |
| 20 | Brian F. Kowal, MDUrology · Hyannis | 46 | 48 | −4% |
| 22 | Kemal Tuncali, MDDiagnostic Radiology · Boston | 45 | 41 | +10% |
| 23 | Filipe L. De Carvalho, MD, PHDUrology · Boston | 42 | 24 | +75% |
| 24 | John J. Homa, DOUrology · Hyannis | 41 | 43 | −5% |
| 25 | Igor Sorokin, MDUrology · Worcester | 40 | 41 | −2% |
A rank counts procedures billed under the physician's own NPI (CPT 55700), in 2024, Medicare fee-for-service only. A surgeon who mostly treats younger or Medicare Advantage patients will rank lower than their total volume. Method and limits.